-

$undefined

N/A

(N/A)

Mesoblast NASDAQ:MESO

Location: L 38 55 Collins St, Victoria, 3000, Australia | Website: http://www.mesoblast.com/ | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

12.5B

Cash

38.03M

Avg Qtr Burn

-10.64M

Short % of Float

0.35%

Insider Ownership

0.06%

Institutional Own.

2.44%

Qtr Updated

12/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RYONCIL™ (Remestemcel-L) Details Acute graft-versus host disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REVASCOR® (Rexlemestrocel) Details Heart disease, Hypoplastic Left Heart Syndrome	BLA Acceptance for review	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REVASCOR® (Rexlemestrocel) Details Ischemic CHF with reduced ejection fraction (HFrEF) and inflammation	BLA FDA meeting	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rexlemestrocel Details Chronic lower back pain	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Remestemcel-L (mesenchymal stem cells) Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Remestemcel-L Details Inflammatory bowel disease, Bowel disorder, Crohns disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.